Immune Negative Regulator TIPE2 Inhibits Cervical Squamous Cancer Progression Through Erk1/2 Signaling

Li-Qiong Huang1, Bo Zheng1, Yi He1

  • 1Department of Obstetrics and Gynecology, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, 228 Jingui Road, Xianning 437100, China.

Open Life Sciences
|April 5, 2021
PubMed

Insights

Tumor necrosis factor-α-induced protein-8-like 2 (TIPE2) inhibits cervical cancer cell growth and spread. Higher TIPE2 levels in tumors correlate with less metastasis, suggesting TIPE2

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Tumor necrosis factor-α-induced protein-8-like 2 (TIPE2) is an immune negative regulator.
  • The role of TIPE2 in cervical squamous cancer progression requires further investigation.

Purpose of the Study:

  • To investigate the function of TIPE2 in cervical squamous cancer cell proliferation and invasion.
  • To explore the association between TIPE2 expression and clinicopathological features, including lymphatic metastasis.
  • To elucidate the mechanism by which TIPE2 affects the extracellular signal-regulated kinase (Erk) signaling pathway.

Main Methods:

  • Western blot and immunohistochemistry (IHC) were used to assess TIPE2 expression in cervical cancer tissues and cell lines (SiHa, C33A).
  • Cell lines were transfected with a TIPE2-encoding plasmid to study its effects on proliferation, migration, and invasion.
  • Western blot analysis was performed to examine the phosphorylation status of Erk1/2 and MEK1/2 signaling pathway components.

Main Results:

  • TIPE2 expression was significantly higher in cervical cancer tissues compared to normal tissues.
  • Higher IHC scores for TIPE2 in tumors were negatively correlated with lymphatic metastasis.
  • Overexpression of TIPE2 suppressed cervical cancer cell proliferation, migration, and invasion in vitro.
  • TIPE2 overexpression reduced the phosphorylation of Erk1/2 and MEK1/2, indicating inhibition of the Erk signaling pathway.

Conclusions:

  • TIPE2 expression is negatively associated with the development and progression of cervical squamous cancer.
  • TIPE2 acts as an inhibitory factor for cervical squamous cancer cell proliferation and invasion.
  • The inhibitory effects of TIPE2 may be mediated through the suppression of the Erk signaling pathway.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
37.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.3K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.5K